Browse by Medical Category
Division of Surgical Oncology
Call to request an appointment or refer a patient:
Located within a world-class academic medical center, Mass General's Pancreas and Biliary Surgery Program includes board-certified, Harvard Medical School-affiliated general surgeons who specialize in performing surgery of the pancreas and biliary system (i.e. gall bladder and bile ducts). This specialization requires rigorous advanced training and a highly focused clinical practice.
Depending on your condition and diagnosis, your treatment team includes your surgeon as well as gastrointestinal specialists in the Tucker Gosnell Center for Gastrointestinal Cancers or the Pancreas and Biliary Center. Your surgeon works side-by-side with your entire Mass General treatment team, including the Cyst Imaging Surveillance and Treatment (CIST) Center, to provide comprehensive, personalized treatment for cancer patients and other patients with complex conditions.
We regularly hold multidisciplinary conferences that are attended by specialists from across Mass General. During these conferences, we collaborate on unique and particularly challenging patient cases. Receiving input from this range of expert perspectives helps us deliver comprehensive care for everything from the most common to the rarest pancreatic and biliary diseases.
We treat a variety of conditions that affect the pancreas, gall bladder or bile ducts, including:
Mass General has the largest pancreatic cancer practice in New England. Our program has a history of pioneering innovative, minimally invasive approaches such as:
We are also highly experienced with specialized procedures such as:
Our surgeons are accomplished researchers who are at the forefront of the latest surgical and medical innovations. Browse online for open clinical trials.
Accepting New Patients
Pancreatic cancer is the fourth most common cause of cancer death in men and women in the US. Pancreatic cancer occurs when malignant cells grow out of control.
Pancreatitis is the inflammation of the pancreas. The inflammation may be sudden (acute) or ongoing (chronic).
Thirty-six former MGH patients, ranging in age from 35 to 81, recently returned to the hospital for the inaugural pancreatic surgery patient symposium, “Through Patients’ Eyes: Understanding Life After Pancreatic Surgery.”
MGH Hotline 6.13.11 On April 26, Andrew L. Warshaw, MD, stepped into the operating room to perform his last procedure after four decades of practice and nearly 14 years as surgeon-in-chief and chair of the MGH Department of Surgery.
MGH Hotline 5.13.11 Keith D. Lillemoe, MD, the MGH's new surgeon-in-chief and chair of the Department of Surgery, spent 27 years at Johns Hopkins and most recently led the Department of Surgery at Indiana University Hospital.
Back to Top